201 related articles for article (PubMed ID: 31160272)
1. Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca
Jimenez H; Wang M; Zimmerman JW; Pennison MJ; Sharma S; Surratt T; Xu ZX; Brezovich I; Absher D; Myers RM; DeYoung B; Caudell DL; Chen D; Lo HW; Lin HK; Godwin DW; Olivier M; Ghanekar A; Chen K; Miller LD; Gong Y; Capstick M; D'Agostino RB; Munden R; Merle P; Barbault A; Blackstock AW; Bonkovsky HL; Yang GY; Jin G; Liu L; Zhang W; Watabe K; Blackman CF; Pasche BC
EBioMedicine; 2019 Jun; 44():209-224. PubMed ID: 31160272
[TBL] [Abstract][Full Text] [Related]
2. Ca
Sharma S; Wu SY; Jimenez H; Xing F; Zhu D; Liu Y; Wu K; Tyagi A; Zhao D; Lo HW; Metheny-Barlow L; Sun P; Bourland JD; Chan MD; Thomas A; Barbault A; D'Agostino RB; Whitlow CT; Kirchner V; Blackman C; Pasche B; Watabe K
EBioMedicine; 2019 Jun; 44():194-208. PubMed ID: 31129098
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.
Chen J; Zhu S; Tong L; Li J; Chen F; Han Y; Zhao M; Xiong W
BMC Cancer; 2014 Feb; 14():114. PubMed ID: 24555445
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels.
Buckner CA; Buckner AL; Koren SA; Persinger MA; Lafrenie RM
PLoS One; 2015; 10(4):e0124136. PubMed ID: 25875081
[TBL] [Abstract][Full Text] [Related]
5. Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway.
Cui Y; Liu X; Yang T; Mei YA; Hu C
Cell Calcium; 2014 Jan; 55(1):48-58. PubMed ID: 24360572
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Costa FP; de Oliveira AC; Meirelles R; Machado MC; Zanesco T; Surjan R; Chammas MC; de Souza Rocha M; Morgan D; Cantor A; Zimmerman J; Brezovich I; Kuster N; Barbault A; Pasche B
Br J Cancer; 2011 Aug; 105(5):640-8. PubMed ID: 21829195
[TBL] [Abstract][Full Text] [Related]
7. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Zimmerman JW; Jimenez H; Pennison MJ; Brezovich I; Morgan D; Mudry A; Costa FP; Barbault A; Pasche B
Chin J Cancer; 2013 Nov; 32(11):573-81. PubMed ID: 24206915
[TBL] [Abstract][Full Text] [Related]
8. Exposure to 835 MHz RF-EMF decreases the expression of calcium channels, inhibits apoptosis, but induces autophagy in the mouse hippocampus.
Kim JH; Sohn UD; Kim HG; Kim HR
Korean J Physiol Pharmacol; 2018 May; 22(3):277-289. PubMed ID: 29719450
[TBL] [Abstract][Full Text] [Related]
9. Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects.
Pall ML
J Cell Mol Med; 2013 Aug; 17(8):958-65. PubMed ID: 23802593
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of B16F10 Cancer Cell Growth by Exposure to the Square Wave with 7.83+/-0.3Hz Involves L- and T-Type Calcium Channels.
Wang MH; Jian MW; Tai YH; Jang LS; Chen CH
Electromagn Biol Med; 2021 Jan; 40(1):150-157. PubMed ID: 33111597
[TBL] [Abstract][Full Text] [Related]
11. TNFα induces Ca
Zhu J; Jin M; Wang J; Zhang H; Wu Y; Li D; Ji X; Yang H; Yin C; Ren T; Xing J
J Exp Clin Cancer Res; 2018 Mar; 37(1):43. PubMed ID: 29506556
[TBL] [Abstract][Full Text] [Related]
12. Low-energy amplitude-modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.
Capareli F; Costa F; Tuszynski JA; Sousa MC; Setogute YC; Lima PD; Carvalho L; Santos E; Gumz BP; Sabbaga J; de Castria TB; Jardim DL; Freitas D; Horvat N; Bezerra ROF; Testagrossa L; Costa T; Zanesco T; Iemma AF; Abou-Alfa GK
Cancer Med; 2023 Jun; 12(11):12402-12412. PubMed ID: 37184216
[TBL] [Abstract][Full Text] [Related]
13. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
14. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
15. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.
Rodríguez MM; Fiore E; Bayo J; Atorrasagasti C; García M; Onorato A; Domínguez L; Malvicini M; Mazzolini G
Mol Ther; 2018 Dec; 26(12):2738-2750. PubMed ID: 30301668
[TBL] [Abstract][Full Text] [Related]
16. T-type voltage gated calcium channels are involved in endothelium-dependent relaxation of mice pulmonary artery.
Gilbert G; Courtois A; Dubois M; Cussac LA; Ducret T; Lory P; Marthan R; Savineau JP; Quignard JF
Biochem Pharmacol; 2017 Aug; 138():61-72. PubMed ID: 28438566
[TBL] [Abstract][Full Text] [Related]
17. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Ohkubo T; Yamazaki J
Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755
[TBL] [Abstract][Full Text] [Related]
18. Effects of radiofrequency electromagnetic fields (RF EMF) on cancer in laboratory animal studies.
Mevissen M; Ward JM; Kopp-Schneider A; McNamee JP; Wood AW; Rivero TM; Thayer K; Straif K
Environ Int; 2022 Mar; 161():107106. PubMed ID: 35091376
[TBL] [Abstract][Full Text] [Related]
19. Effects of Radiofrequency Electromagnetic Field (RF-EMF) exposure on male fertility and pregnancy and birth outcomes: Protocols for a systematic review of experimental studies in non-human mammals and in human sperm exposed in vitro.
Pacchierotti F; Ardoino L; Benassi B; Consales C; Cordelli E; Eleuteri P; Marino C; Sciortino M; Brinkworth MH; Chen G; McNamee JP; Wood AW; Hooijmans CR; de Vries RBM
Environ Int; 2021 Dec; 157():106806. PubMed ID: 34454359
[TBL] [Abstract][Full Text] [Related]
20. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
